Why Is Micro-Cap AIM ImmunoTech Stock Surging?
AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer patients. read more
AIM ImmunoTech shares rise after DURIPANC trial data show superior survival and safety in metastatic pancreatic cancer patients. read more
ChargePoint Holdings Inc (NYSE:CHPT) shares are moving lower Monday after the company announced a 1-for-20 reverse stock split. read more
Shares of Palantir Technologies are trading flat Monday morning. Investors are digesting a week that saw the stock hit a new all-time high. read more
Shares of NIO are trading flat Monday. The stock is holding steady after a marked 43% rally over the past month. read more